DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Q3 2025 vs. Q2 2025
How the institutions holding DBV Technologies S.A. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 29 | 33 | +4 |
| Shares | 7.23M | 6.52M | −713.4K (−9.9%) |
| Value | $66.2M | $65.2M | −$1.03M (−1.6%) |
New holders (8)
Institutions that held DBV Technologies S.A. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Artisan Partners Limited Partnership | 51,920 | $519.2K | 0.00% |
| DLD Asset Management, LP | 25,000 | $250.0K | 0.03% |
| Citadel Advisors LLC | 22,049 | $220.5K | 0.00% |
| Two Sigma Investments, LP | 16,682 | $166.8K | 0.00% |
| New York State Common Retirement Fund | 3,420 | $34.2K | 0.00% |
| Toronto Dominion Bank | 320 | $3.20K | 0.00% |
| Advisory Services Network, LLC | 130 | $1.30K | 0.00% |
| BlackRock, Inc. | 2 | $20 | 0.00% |
Sold out (4)
Institutions that held DBV Technologies S.A. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| MYDA Advisors LLC | 30,220 | $276.8K |
| Point72 Asset Management, L.P. | 17,000 | $155.7K |
| Steward Partners Investment Advisory, LLC | 1,518 | $13.9K |
| Raymond James Financial Inc | 916 | $8.39K |